Tablet case
Latest Warner Lambert Company LLC Patents:
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
- Antibodies to M-CSF
FIG. 1 is a front perspective view of a tablet case.
FIG. 2 is a left side elevation view of the tablet case.
FIG. 3 is a top plan view of the tablet case.
FIG. 4 is a right side elevation view of the tablet case.
FIG. 5 is a front elevation view of the tablet case.
FIG. 6 is a bottom plan view of the tablet case; and,
FIG. 7 is a front perspective view of the tablet case showing various blister cards that may be stored in the tablet case.
The ornamental design for the tablet case which is claimed is shown in solid lines in the drawings. The broken lines in the drawings, showing different blister cards and tablets that may be stored in the tablet case, are for illustrative purposes only and form no part of the claimed design.
Claims
We claim the ornamental design for a tablet case, as shown and described.
Type: Grant
Filed: Nov 4, 2004
Date of Patent: Feb 7, 2006
Assignee: Warner Lambert Company LLC (Morris Plains, NJ)
Inventors: Stephen Don Wahl (Palo Alto, CA), Aaron Richard Servier (San Francisco, CA), Robert Peter Arko (Palo Alto, CA)
Primary Examiner: Catherine R. Oliver
Attorney: Evan J. Federman
Application Number: 29/216,529
